Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Is suppressing appetite pharmacologically really such a bad thing
Fat loss, not muscle loss, drove almost every meaningful functional improvement
Clinical studies demonstrated significant improvements in disease activity scores and quality of life measures
Weight Loss Consultation With Dr
Only two clinical trials made it into the review
Functional Performance Profile Key Benefits Triple Agonist: GLP-1, GIP & Glucagon Advanced Weight Loss Muscle Preservation Metabolic Optimisation Improved Energy & Focus Product Specifications Purity: 99.8% Form: Lyophilized peptide Storage: 2-9C Refrigerated Research Information Type: Triple receptor agonist Pathways: GLP-1 / GIP / Glucagon Focus: Metabolic regulation Scientific Information Research Reference Parameters Laboratory Use Only Initial phase: 2-4 mg once weekly Standard research range: 5-8 mg once weekly Advanced research range: 8-12 mg once weekly Research cycles typically extend 8-16 weeks Mechanism of Action Retatrutide functions as a triple agonist: GIP activation enhances insulin secretion and fat metabolism
